Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China

RONG Hongguo; HAO Jiaxin; HAN Mei; LIU Jianping; FEI Yutong

doi:10.6039/j.issn.1001-0408.2023.16.01

您当前的位置：

首页 >

文章列表页 >

Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China

更新时间：2025-09-25

- Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China
- ZHONGGUO YAOFANG Vol. 34, Issue 16, Pages: 1921-1925(2023)
- 作者机构：
  
  1.北京中医药大学中医学院，北京　100029
  2.北京中医药大学循证医学中心，北京　100029
  3.北京中医药大学国际循证中医药研究院，北京　100029
  4.北京中医药大学国家中医药发展与战略研究院，北京　100029
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.16.01
  CLC： R95;R288
- Received：14 April 2023，
  
  Revised：2023-07-20，
  
  Accepted：24 July 2023，
  
  Published：30 August 2023
- 稿件说明：
移动端阅览
荣红国,郝佳欣,韩梅,等.我国中成药临床综合评价研究热点与趋势分析[J].中国药房,2023,34(16):1921-1925.

RONG Hongguo,HAO Jiaxin,HAN Mei,et al.Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China[J].ZHONGGUO YAOFANG,2023,34(16):1921-1925.
荣红国,郝佳欣,韩梅,等.我国中成药临床综合评价研究热点与趋势分析[J].中国药房,2023,34(16):1921-1925. DOI： 10.6039/j.issn.1001-0408.2023.16.01.

RONG Hongguo,HAO Jiaxin,HAN Mei,et al.Analysis of research hotspots and trend of the clinical comprehensive evaluation of Chinese patent medicine in China[J].ZHONGGUO YAOFANG,2023,34(16):1921-1925. DOI： 10.6039/j.issn.1001-0408.2023.16.01.

摘要

目的

分析我国中成药临床综合评价研究领域的研究现状、热点与趋势。

方法

基于中国知网、维普网和万方数据，以中成药临床综合评价为主题进行检索，检索时限为建库至2022年10月30日。采用CiteSpace 6.1.R3和VOSviewer软件对我国中成药临床综合评价相关文献的年度发文情况、作者、机构、关键词等信息进行可视化分析。

结果与结论

本研究共纳入中成药临床综合评价相关文献1 460篇，年发文量总体呈增长趋势。纳入文献共有发文作者714位，发文量较多的机构有中国中医科学院、北京中医药大学和天津中医药大学等，发文作者团队及机构间合作较少；高频关键词为中成药、安全性、不良反应、合理用药等；研究热点为中成药的安全性评价和有效性评价；加强中成药处方点评，构建多维度、多准则的中成药合理用药临床综合评价体系，保障中成药合理应用可能成为该领域的研究趋势。

Abstract

OBJECTIVE

To analyze the research status， hotspots， and trend of the clinical comprehensive evaluation of Chinese patent medicine in China.

METHODS

Based on CNKI， VIP and Wanfang database， clinical comprehensive evaluation of Chinese patent medicine was used as the subject of retrieval， and the retrieval time was from the inception to October 30th， 2022. CiteSpace 6.1.R3 and VOSviewer were used to conduct a visualization analysis of the relative literature of clinical comprehensive evaluation of Chinese patent medicine in terms of annual publication quantity， authors， institutions， keywords， etc.

RESULTS &CONCLUSIONS

A total of 1 460 pieces of literature related to the clinical comprehensive evaluation of Chinese patent medicine were included. The overall annual publication quantity showed a growth trend. There were 714 authors in the included literature. The institutions with a large publication quantity included the Chinese Academy of Traditional Chinese Medicine， Beijing University of Chinese Medicine， Tianjin University of Traditional Chinese Medicine， etc.， and there was little cooperation among the authors and institutions. High-frequency keywords included Chinese patent medicine， safety， adverse drug reactions， rational drug use， etc. Research hotspots focused on the safety and effectiveness evaluation of Chinese patent medicine. It may be a research trend in this field to strengthen the prescription review of Chinese patent medicine， and build a multi-dimensional and multi-criteria clinical comprehensive evaluation system for the rational use of Chinese patent medicine.

关键词

Keywords

references

杨金伟 . 药品临床综合评价管理指南发布：聚焦两条主线　注重六个维度 [N ] . 健康报， 2021-07-29 （001）.

元唯安，张俊华，刘建平，等 . 中成药临床综合评价指南：2022年版试行 [J ] . 中国中药杂志， 2023 ， 48 （ 1 ）： 256 - 264 .

陈悦，陈超美，刘则渊，等 . CiteSpace知识图谱的方法论功能 [J ] . 科学学研究， 2015 ， 33 （ 2 ）： 242 - 253 .

耿向楠，韩晟，肖鲁，等 . 我国基本药物经济性评价方法初探 [J ] . 中国药学杂志， 2011 ， 46 （ 12 ）： 963 - 966 .

唐显帅，郑磊，张明珠，等 . 基于循证医学证据和药物经济学模型的中成药临床综合评价 [J ] . 中国药房， 2022 ， 33 （ 15 ）： 1870 - 1875 .

卢林帆 . 稳心颗粒联合美托洛尔治疗冠心病心律失常疗效分析 [J ] . 中国医药指南， 2011 ， 9 （ 12 ）： 34 - 35 .

王学胜，张学平，陈慧 . 稳心颗粒联合美托洛尔治疗老年人冠心病心律失常的临床疗效观察 [J ] . 中华老年医学杂志， 2013 ， 32 （ 11 ）： 1159 - 1160 .

胡盛寿，高润霖，刘力生，等 . 《中国心血管病报告2018》概要 [J ] . 中国循环杂志， 2019 ， 34 （ 3 ）： 209 - 220 .

国家药物和卫生技术综合评估中心（国家卫生健康委卫生发展研究中心） . 心血管病药品临床综合评价技术指南：2022年版试行 [EB/OL ] .（ 2022-06-29 ）[ 2023-02-01 ] . http：//www.nhei.cn/nhei/znfb/202206/c01d87a290664b0-1bf42a9dad769d69f.shtml http://www.nhei.cn/nhei/znfb/202206/c01d87a290664b0-1bf42a9dad769d69f.shtml .

王宇光，李红燕，孔祥文 . 基于处方点评的中成药临床合理用药关键要素探讨 [J ] . 中国药房， 2014 ， 25 （ 11 ）： 970 - 972 .

金锐，赵奎君，郭桂明，等 . 中成药临床合理用药处方点评北京共识 [J ] . 中国中药杂志， 2018 ， 43 （ 5 ）： 1049 - 1053 .

Views

321

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Traditional Chinese medicine in the treatment of ulcerative colitis in 2013-2023： a bibliometric analysis

Artificial intelligence application in hospital pharmaceutical service： a bibliometric analysis

Visual analysis of tyrosine kinase inhibitors in HER2 positive breast cancer

Visualization analysis of the therapy of recurrent high-grade gliomas based on CiteSpace

Visual analysis of the treatment of non-alcoholic fatty liver disease based on Web of Science

Related Author

DOU Danbo

ZENG Cheng

HUANG Shiyun

GU Sizhen

PENG Jun

FU Suqin

HAO Chenye

ZOU Jing

Related Institution

Dept. of Traditional Medicine， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dongming Community Health Service Center， Shanghai Pudong New Area

Library & Information Center， Shanghai University of Medicine & Health Sciences

Dept. of Pharmacy， the First Affiliated Hospital of Zhengzhou University

Dept. of Pharmacy， Beijing Tiantan Hospital Affiliated to Capital Medical University

⁰